{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:21:02Z","timestamp":1783030862807,"version":"3.54.6"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.schres.2021.03.012","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T14:54:05Z","timestamp":1618325645000},"page":"145-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effectiveness of multimodal interventions focused on smoking cessation in patients with schizophrenia: A systematic review"],"prefix":"10.1016","volume":"231","author":[{"given":"Sofia","family":"Pinho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Vieira-Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.schres.2021.03.012_bb0005","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1176\/ps.49.7.925","article-title":"Group treatment for smoking cessation among persons with schizophrenia","volume":"49","author":"Addington","year":"1998","journal-title":"Psychiatr. Serv."},{"issue":"7","key":"10.1016\/j.schres.2021.03.012_bb0010","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1176\/ajp.155.7.974","article-title":"Smoking cessation treatment for patients with schizophrenia","volume":"155","author":"Addington","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.03.012_bb0015","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fpsyt.2018.00428","article-title":"Efficacy and safety of varenicline for smoking cessation in schizophrenia: a meta-analysis","volume":"9","author":"Ahmed","year":"2018","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.schres.2021.03.012_bb0025","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5\u00ae)","year":"2013"},{"issue":"10037","key":"10.1016\/j.schres.2021.03.012_bb0020","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"issue":"6\u20137","key":"10.1016\/j.schres.2021.03.012_bb0030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/j.1440-1614.2006.01841.x","article-title":"Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use?","volume":"40","author":"Barnes","year":"2006","journal-title":"Aust N Z J Psychiatry"},{"issue":"5 Suppl","key":"10.1016\/j.schres.2021.03.012_bb0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0269881112440512","article-title":"A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications","volume":"26","author":"Beary","year":"2012","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2021.03.012_bb0040","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.4081\/hpr.2020.9237","article-title":"Approved and emerging smoking cessation treatments for people with schizophrenia spectrum disorders: a narrative review","volume":"8","author":"Caponnetto","year":"2020","journal-title":"Health Psychol. Res."},{"issue":"3","key":"10.1016\/j.schres.2021.03.012_bb0045","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/00952990701301319","article-title":"A perfect platform: combining contingency management with medications for drug abuse","volume":"33","author":"Carroll","year":"2007","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.schres.2021.03.012_bb0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1017\/S1092852900015959","article-title":"Acute and long-term adverse effects of antipsychotics","volume":"12","author":"Correll","year":"2007","journal-title":"CNS Spectr."},{"issue":"5","key":"10.1016\/j.schres.2021.03.012_bb0055","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1360-0443.1991.tb01798.x","article-title":"Understanding brain mechanisms in nicotine reinforcement","volume":"86","author":"Corrigall","year":"1991","journal-title":"Br. J. Addict."},{"issue":"2\u20133","key":"10.1016\/j.schres.2021.03.012_bb0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2005.02.010","article-title":"A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors","volume":"76","author":"de Leon","year":"2005","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2021.03.012_bb0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1176\/appi.ps.201700118","article-title":"Cigarette smoking by patients with serious mental illness, 1999-2016: an increasing disparity","volume":"69","author":"Dickerson","year":"2018","journal-title":"Psychiatr. Serv."},{"issue":"3","key":"10.1016\/j.schres.2021.03.012_bb0070","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1139\/jpn.0425","article-title":"What is the role of pharmacotherapy in tobacco cessation in patients with schizophrenia?","volume":"29","author":"Els","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"issue":"4","key":"10.1016\/j.schres.2021.03.012_bb0075","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/14622200110073920","article-title":"A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia","volume":"3","author":"Evins","year":"2001","journal-title":"Nicotine Tob. Res."},{"issue":"4","key":"10.1016\/j.schres.2021.03.012_bb0080","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/01.jcp.0b013e3180ca86fa","article-title":"A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia","volume":"27","author":"Evins","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2021.03.012_bb0085","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0006-3223(94)00252-X","article-title":"Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia","volume":"38","author":"Freedman","year":"1995","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2021.03.012_bb0090","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.157.11.1835","article-title":"Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia","volume":"157","author":"George","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2021.03.012_bb0095","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1176\/ajp.150.4.546","article-title":"Cigarette smoking: implications for psychiatric illness","volume":"150","author":"Glassman","year":"1993","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2021.03.012_bb0100","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/archpsyc.1994.03950070060011","article-title":"Incentives improve outcome in outpatient behavioral treatment of cocaine dependence","volume":"51","author":"Higgins","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2021.03.012_bb0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0014-2999(86)90629-1","article-title":"Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats","volume":"132","author":"Imperato","year":"1986","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.schres.2021.03.012_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control. Clin. Trials"},{"issue":"2","key":"10.1016\/j.schres.2021.03.012_bb0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.15585\/mmwr.mm6702a1","article-title":"Current cigarette smoking among adults - United States, 2016","volume":"67","author":"Jamal","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"5","key":"10.1016\/j.schres.2021.03.012_bb0120","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2165\/00003495-200262050-00003","article-title":"Substance misuse in patients with schizophrenia: epidemiology and management","volume":"62","author":"Kavanagh","year":"2002","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.schres.2021.03.012_bb0125","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/schbul\/sbp152","article-title":"Cigarette smoking and mortality risk in people with schizophrenia","volume":"37","author":"Kelly","year":"2011","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.schres.2021.03.012_bb0130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1744-6163.2006.00085.x","article-title":"Smoke, smoke, smoke that cigarette","volume":"42","author":"Keltner","year":"2006","journal-title":"Perspect Psychiatr. Care"},{"issue":"5","key":"10.1016\/j.schres.2021.03.012_bb0135","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1176\/ajp.2007.164.5.827b","article-title":"Readiness to quit and smoking reduction outcomes","volume":"164","author":"Lan","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"8 Pt 1","key":"10.1016\/j.schres.2021.03.012_bb0140","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2105\/AJPH.85.8_Pt_1.1169","article-title":"Reducing smoking among psychiatric inpatients: a survey of psychiatrists","volume":"85","author":"Landow","year":"1995","journal-title":"Am. J. Public Health"},{"issue":"1\u20133","key":"10.1016\/j.schres.2021.03.012_bb0145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.schres.2014.08.014","article-title":"Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications","volume":"163","author":"Lee","year":"2015","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2021.03.012_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0920-9964(92)90024-Y","article-title":"Smoking and schizophrenia","volume":"8","author":"Lohr","year":"1992","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2021.03.012_bb0155","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.schres.2010.10.030","article-title":"Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program","volume":"126","author":"Mann-Wrobel","year":"2011","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2021.03.012_bb0160","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1360-0443.2002.00064.x","article-title":"Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment?","volume":"97","author":"McChargue","year":"2002","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.schres.2021.03.012_bb0165","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.3390\/ijerph10104790","article-title":"Smoking behaviour and mental health disorders--mutual influences and implications for therapy","volume":"10","author":"Minichino","year":"2013","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"1","key":"10.1016\/j.schres.2021.03.012_bb0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.genhosppsych.2014.11.006","article-title":"Do people with mental illness receive adequate smoking cessation advice? A systematic review and meta-analysis","volume":"37","author":"Mitchell","year":"2015","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2021.03.012_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"11","key":"10.1016\/j.schres.2021.03.012_bb0180","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027389","article-title":"Pharmacological and behavioural interventions to promote smoking cessation in adults with schizophrenia and bipolar disorders: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Pearsall","year":"2019","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.schres.2021.03.012_bb0185","doi-asserted-by":"crossref","first-page":"108","DOI":"10.24869\/psyd.2017.108","article-title":"Causes of mortality in schizophrenia: an updated review of European studies","volume":"29","author":"Piotrowski","year":"2017","journal-title":"Psychiatr. Danub."},{"issue":"9590","key":"10.1016\/j.schres.2021.03.012_bb0190","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(07)61238-0","article-title":"No health without mental health","volume":"370","author":"Prince","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2021.03.012_bb0195","first-page":"58","article-title":"Multimodal treatment for smoking cessation with varenicline in alcoholic, methadone-maintained, and psychotic patients: a one-year follow-up","volume":"16","author":"Raich","year":"2018","journal-title":"Tob. Induc. Dis."},{"issue":"9","key":"10.1016\/j.schres.2021.03.012_bb0200","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S2215-0366(20)30261-3","article-title":"Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis","volume":"7","author":"Siskind","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2021.03.012_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143490","article-title":"Varenicline effects on smoking, cognition, and psychiatric symptoms in schizophrenia: a double-blind randomized trial","volume":"11","author":"Smith","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.schres.2021.03.012_bb0210","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaut.2006.07.006","article-title":"Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited","volume":"27","author":"Strous","year":"2006","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.schres.2021.03.012_bb0215","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/acps.12412","article-title":"How can we promote smoking cessation in people with schizophrenia in practice? A clinical overview","volume":"132","author":"Stubbs","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.schres.2021.03.012_bb0220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1037\/1064-1297.10.3.241","article-title":"Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia","volume":"10","author":"Tidey","year":"2002","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2021.03.012_bb0225","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00213-011-2282-8","article-title":"Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia","volume":"217","author":"Tidey","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2021.03.012_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007253.pub2","article-title":"Interventions for smoking cessation and reduction in individuals with schizophrenia","volume":"6","author":"Tsoi","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.schres.2021.03.012_bb0235","doi-asserted-by":"crossref","unstructured":"Tsoi, D.T., Porwal, M., Webster, A.C., 2013. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst. Rev. 2013(2), Cd007253.DOI: https:\/\/doi.org\/10.1002\/14651858.CD007253.pub3.","DOI":"10.1002\/14651858.CD007253.pub3"},{"issue":"4","key":"10.1016\/j.schres.2021.03.012_bb0240","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1176\/appi.ajp.158.4.635","article-title":"Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia","volume":"158","author":"Weiner","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2021.03.012_bb0245","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4088\/JCP.10m06143gre","article-title":"Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis","volume":"73","author":"Weiner","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.schres.2021.03.012_bb0250","series-title":"Global Health Risks\u202f: Mortality and Burden of Disease Attributable to Selected Major Risks","author":"WHO","year":"2009"},{"issue":"2","key":"10.1016\/j.schres.2021.03.012_bb0255","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1176\/ajp.2007.164.2.222","article-title":"Successful tobacco dependence treatment in schizophrenia","volume":"164","author":"Williams","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2021.03.012_bb0260","first-page":"27","article-title":"Snuffing out tobacco dependence. Ten reasons behavioral health providers need to be involved","volume":"26","author":"Williams","year":"2006","journal-title":"Behav Healthc"},{"issue":"4","key":"10.1016\/j.schres.2021.03.012_bb0265","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jsat.2010.03.006","article-title":"Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder","volume":"38","author":"Williams","year":"2010","journal-title":"J. Subst. Abus. Treat."},{"issue":"1","key":"10.1016\/j.schres.2021.03.012_bb0270","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0006-3223(87)90131-4","article-title":"Nicotine exposure and tardive dyskinesia","volume":"22","author":"Yassa","year":"1987","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2021.03.012_bb0275","doi-asserted-by":"crossref","first-page":"102190","DOI":"10.1016\/j.ajp.2020.102190","article-title":"Worldwide prevalence of smoking cessation in schizophrenia patients: a meta-analysis of comparative and observational studies","volume":"54","author":"Zeng","year":"2020","journal-title":"Asian J. Psychiatr."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421001328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421001328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:42:27Z","timestamp":1760298147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996421001328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":55,"alternative-id":["S0920996421001328"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2021.03.012","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of multimodal interventions focused on smoking cessation in patients with schizophrenia: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2021.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}